Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Jan

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Molecular Therapy. Methods & Clinical Development|August 14, 2019
Gene Therapy for Parkinson's Disease: Preclinical Evaluation of Optimally Configured TH:CH1 Fusion for Maximal Dopamine SynthesisRomina Aron Badin, Katie Binley, Nadja Van Camp, et al.
Neurobiology of Disease|April 13, 2023
Development of an AAV-based model of tauopathy targeting retinal ganglion cells and the mouse visual pathway to study the role of microglia in Tau pathologyCharlotte Duwat, Pauline Léal, Audrey Vautheny, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 19, 2014
Impaired brain energy metabolism in the BACHD mouse model of Huntington's disease: critical role of astrocyte-neuron interactionsLydie Boussicault, Anne-Sophie Hérard, Noel Calingasan, et al.
Science Translational Medicine|April 7, 2010
Dopamine gene therapy for Parkinson's disease in a nonhuman primate without associated dyskinesiaBéchir Jarraya, Sabrina Boulet, G Scott Ralph, et al.
Neurobiology of Disease|October 13, 2019
The C-terminal domain of LRRK2 with the G2019S mutation is sufficient to produce neurodegeneration of dopaminergic neurons in vivoNoémie Cresto, Marie-Claude Gaillard, Camille Gardier, et al.
Glia|March 22, 2025
Hippocampal Astrocyte Morphology Follows an Unexpected Trajectory With Age in a Transgenic Rodent Model of TauopathyEmma Augustin, Tatiana Vinasco-Sandoval, Miriam Riquelme-Perez, et al.
Brain : a Journal of Neurology|April 12, 2021
Neuronal tau species transfer to astrocytes and induce their loss according to tau aggregation stateAnastasie Maté de Gérando, Marie d'Orange, Emma Augustin, et al.
International Journal of Molecular Sciences|July 2, 2021
The C-Terminal Domain of LRRK2 with the G2019S Substitution Increases Mutant A53T α-Synuclein Toxicity in Dopaminergic Neurons In VivoNoémie Cresto, Camille Gardier, Marie-Claude Gaillard, et al.
Brain : a Journal of Neurology|February 5, 2025
Loss of the neuronal kinase DCLK3 leads to anxiety-like behaviour and memory deficitsLucie de Longprez, Marie-Claude Gaillard, Charles Decraene, et al.
Brain : a Journal of Neurology|March 14, 2018
The striatal kinase DCLK3 produces neuroprotection against mutant huntingtinLaurie Galvan, Laetitia Francelle, Marie-Claude Gaillard, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Molecular Therapy. Methods & Clinical Development|August 14, 2019
Gene Therapy for Parkinson's Disease: Preclinical Evaluation of Optimally Configured TH:CH1 Fusion for Maximal Dopamine SynthesisRomina Aron Badin, Katie Binley, Nadja Van Camp, et al.
Neurobiology of Disease|April 13, 2023
Development of an AAV-based model of tauopathy targeting retinal ganglion cells and the mouse visual pathway to study the role of microglia in Tau pathologyCharlotte Duwat, Pauline Léal, Audrey Vautheny, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 19, 2014
Impaired brain energy metabolism in the BACHD mouse model of Huntington's disease: critical role of astrocyte-neuron interactionsLydie Boussicault, Anne-Sophie Hérard, Noel Calingasan, et al.
Science Translational Medicine|April 7, 2010
Dopamine gene therapy for Parkinson's disease in a nonhuman primate without associated dyskinesiaBéchir Jarraya, Sabrina Boulet, G Scott Ralph, et al.
Neurobiology of Disease|October 13, 2019
The C-terminal domain of LRRK2 with the G2019S mutation is sufficient to produce neurodegeneration of dopaminergic neurons in vivoNoémie Cresto, Marie-Claude Gaillard, Camille Gardier, et al.
Glia|March 22, 2025
Hippocampal Astrocyte Morphology Follows an Unexpected Trajectory With Age in a Transgenic Rodent Model of TauopathyEmma Augustin, Tatiana Vinasco-Sandoval, Miriam Riquelme-Perez, et al.
Brain : a Journal of Neurology|April 12, 2021
Neuronal tau species transfer to astrocytes and induce their loss according to tau aggregation stateAnastasie Maté de Gérando, Marie d'Orange, Emma Augustin, et al.
International Journal of Molecular Sciences|July 2, 2021
The C-Terminal Domain of LRRK2 with the G2019S Substitution Increases Mutant A53T α-Synuclein Toxicity in Dopaminergic Neurons In VivoNoémie Cresto, Camille Gardier, Marie-Claude Gaillard, et al.
Brain : a Journal of Neurology|February 5, 2025
Loss of the neuronal kinase DCLK3 leads to anxiety-like behaviour and memory deficitsLucie de Longprez, Marie-Claude Gaillard, Charles Decraene, et al.
Brain : a Journal of Neurology|March 14, 2018
The striatal kinase DCLK3 produces neuroprotection against mutant huntingtinLaurie Galvan, Laetitia Francelle, Marie-Claude Gaillard, et al.
Pageof 4